Trial intelligence / Profile preview

Randomized placebo-controlled study of oral moxaverine on ocular blood flow in healthy subjects

2009-017789-22Phase 2Completed

Sponsor
URSAPHARM
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in Retinal Microvascular Disease comparing Moxaverine hydrochloride oral with Placebo oral (2 arms). Primary endpoints: Choroidal blood flow and Optic nerve head blood flow. Started Apr 2010; status: completed.

02

Drugs

moxaverine
03

Conditions

Retinal Microvascular Disease

Beyond the preview

Go deeper on 2009-017789-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017789-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call